Felippe Pereira Barone

Felippe Pereira Barone

Auto-generated profile, based on publicly available information

Felippe Pereira Barone

Faculdade de Odontologia, Universidade de São Paulo

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2024 in Clinics
Verified
Journal Article
Open access
GFGiovanna Piacenza Florezi
Giovanna Piacenza Florezi
FBFelippe Pereira Barone
Felippe Pereira Barone
Mario Augusto IzidoroMario Augusto Izidoro
Mario Augusto Izidoro
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
CCCláudia M. Coutinho-Camillo
Cláudia M. Coutinho-Camillo
SLSilvia Vanessa Lourenco
Silvia Vanessa Lourenco
Sjögren's Syndrome (SS) is a chronic inflammatory autoimmune exocrinopathy, and although, the role of metabolism in the autoimmune responses has been discussed in diseases such as lupus erythematosus, rheumatoid arthritis, psoriasis and scleroderma. There is a lack of information regarding the metabolic implications of SS. Considering that the disease affects primarily salivary glands; the aim of this study is to evaluate the metabolic changes in the salivary glands' microenvironment using a targeted metabolomics approach. The saliva from 10 patients diagnosed with SS by the American-European consensus and 10 healthy volunteers was analyzed in an Ultra-high Performance Liquid Chromatograph Coupled Mass Spectrometry (UPLC-MS). The results showed an increased concentration in SS of metabolites involved in oxidative stress such as lactate, alanine and malate, and amino acids involved in the growth and proliferation of T-cells, such as arginine, leucine valine and isoleucine. These results revealed that is possible to differentiate the metabolic profile of SS and healthy individuals using a small amount of saliva, which in its turn may reflect the cellular changes observed in the microenvironments of damaged salivary glands from these patients.

1 May 2025 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
GFGiovanna Piacenza Florezi
Giovanna Piacenza Florezi
FBFelippe P. Barone
Felippe P. Barone
CPCibele Pelissari
Cibele Pelissari
MSMuhammad S Soyfoo
Muhammad S Soyfoo
CDChristine Delporte
Christine Delporte
SLSilvia Vanessa Lourenco
Silvia Vanessa Lourenco

27 March 2025 in Oral Diseases
Verified
Journal Article
Closed access
GFGiovanna Piacenza Florezi
Giovanna Piacenza Florezi
MLMônica Teresa Veneziano Labate
Mônica Teresa Veneziano Labate
LALabate Carlos Alberto
Labate Carlos Alberto
FBFelippe P. Barone
Felippe P. Barone
SLSilvia Vanessa Lourenco
Silvia Vanessa Lourenco

18 December 2025 in Lupus
Verified
Journal Article
Closed access
GFGiovanna Piacenza Florezi
Giovanna Piacenza Florezi
FBFelippe P. Barone
Felippe P. Barone
MLMônica T. V. Labate
Mônica T. V. Labate
CLCarlos A. Labate
Carlos A. Labate
MNMarcello Nico
Marcello Nico
SLSilvia Vanessa Lourenco
Silvia Vanessa Lourenco
Background: Cutaneous lupus erythematosus (CLE) is a complex autoimmune condition with limited data on its molecular underpinnings. Saliva, as plasma filtrate fluid may be a promising tool for biomarkers discovery, given its easy accessibility. Objective: This study aimed to characterize the salivary proteomic profile of CLE patients compared to healthy controls to identify potential disease-specific biomarkers. Methods: Ten females diagnosed with CLE and eleven controls without autoimmune conditions were included in the study. Saliva samples were collected under controlled conditions and analysed using mass spectrometry and chromatography, performed with the nanoElute nanoflow system coupled to a timsTof-Pro mass spectrometer. Results: Among the 104 proteins identified, six showed statistically significant differences between groups. PEBP1 (RKIP), ARG1, TALDO, and CTSZ were upregulated in CLE, while TFF3 and PRDX4 were absent. PEBP1 and ARG1 showed high discriminatory power (AUROC = 1.0), suggesting their potential as CLE biomarkers. Data are available via ProteomeXchange with identifier PXD064580. Conclusion: This study establishes a distinct salivary proteomic signature in CLE, highlighting proteins with diagnostic potential. Saliva proteomics offers a powerful approach to unravel CLE pathophysiology supporting future research on non-invasive biomarkers for disease monitoring and personalized care.